Prostaglandins in Inflammatory Bowel Disease Therapy

Prostaglandins in Inflammatory Bowel Disease Therapy

Saved in:

Bibliographic Details
Main Authors:	Lonnie R Empey, Richard N Fedorak
Format:	Article
Language:	English
Published:	Wiley 1993-01-01
Series:	Canadian Journal of Gastroenterology
Online Access:	http://dx.doi.org/10.1155/1993/218735
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Cyclosporine: Is There a Role in Inflammatory Bowel Disease?
by: Richard N. Fedorak
Published: (1988-01-01)

Urinary prostaglandin metabolites evaluation for activity monitoring in inflammatory bowel disease
by: Renata d’Inca, et al.
Published: (2025-01-01)

Vitamin E Prevents Cold Wrap Restraint Stress-Induced Intestinal Fluid Transport Alterations in Rats
by: Scott Burdick, et al.
Published: (1994-01-01)

Environment and the Inflammatory Bowel Diseases
by: Alexandra Frolkis, et al.
Published: (2013-01-01)

Development and Validation of an Administrative Case Definition for Inflammatory Bowel Diseases
by: Ali Rezaie, et al.
Published: (2012-01-01)

Trends in Inflammatory Bowel Disease Therapy
by: F Martin, et al.
Published: (1993-01-01)

Canadian Digestive Health Foundation Public Impact Series. Inflammatory Bowel Disease in Canada: Incidence, Prevalence, and Direct and Indirect Economic Impact
by: Richard N Fedorak, et al.
Published: (2010-01-01)

Dual Therapy in Inflammatory Bowel Disease
by: Gabriele Altieri, et al.
Published: (2025-02-01)

Living with Inflammatory Bowel Disease: A Crohn’s and Colitis Canada Survey
by: Helen M Becker, et al.
Published: (2015-01-01)

Inflammatory bowel disease and nutritional support therapy
by: Zhi-Han XU, et al.
Published: (2022-08-01)

ANTI-CYTOKINE THERAPY FOR CHILDREN WITH INFLAMMATORY BOWEL DISEASES
by: A.S. Potapov, et al.
Published: (2009-02-01)

Thiopurine Methyltransferase Enzyme Activity Determination before Treatment of Inflammatory Bowel Disease with Azathioprine: Effect on Cost and Adverse Events
by: Farzana A Sayani, et al.
Published: (2005-01-01)

The Social Toll of Inflammatory Bowel Disease
by: Richard G Farmer
Published: (1994-01-01)

The Bowel Microbiota and Inflammatory Bowel Diseases
by: Gerald W. Tannock
Published: (2010-01-01)

Bowel Urgency in Inflammatory Bowel Disease
by: Teodora SPATARU, et al.
Published: (2025-06-01)

Therapy of Inflammatory Bowel Disease: A Surgeon’s Perspective
by: Zane Cohen
Published: (1996-01-01)

Mast Cells as Targets for the Therapy of Inflammatory Bowel Disease
by: EY Bissonnette, et al.
Published: (1990-01-01)

Pathogenesis and therapy of anemia in patients with inflammatory bowel diseases
by: O. V. Rybina, et al.
Published: (2024-04-01)

What is Inflammatory Bowel Disease?
by: Laurington R DaCosta
Published: (1993-01-01)

Epigenetics and the Developmental Origins of Inflammatory Bowel Diseases
by: Richard Kellermayer
Published: (2012-01-01)

Inflammatory Bowel Disease
by: David B. Sachar, et al.
Published: (2012-01-01)

Overview of Subsequent Entry Biologics for the Management of Inflammatory Bowel Disease and Canadian Association of Gastroenterology Position Statement on Subsequent Entry Biologics
by: Shane M Devlin, et al.
Published: (2013-01-01)

Inflammatory Mediators in Inflammatory Bowel Disease
by: BM Peskar
Published: (1990-01-01)

TNF Blocking Therapies and Immunomonitoring in Patients with Inflammatory Bowel Disease
by: Romain Altwegg, et al.
Published: (2014-01-01)

Budesonide for the Treatment of Inflammatory Bowel Disease
by: Gordon R Greenberg
Published: (1994-01-01)

Angiogenesis in Inflammatory Bowel Disease
by: Canan Alkim, et al.
Published: (2015-01-01)

Inflammatory Bowel Disease Video
by: ABR Thomson
Published: (1994-01-01)

Immunopathogenesis of inflammatory bowel diseases
by: Ye. A. Konovich, et al.
Published: (2013-09-01)

Inflammatory bowel disease and proteinuria
by: Yang Zhi-hui, et al.
Published: (2022-12-01)

Anemia in Inflammatory Bowel Disease: A Neglected Issue in Comprehensive Inflammatory Bowel Disease Management
by: Randy Adiwinata, et al.
Published: (2021-10-01)

Sellar Inflammatory Mass with Inflammatory Bowel Disease
by: Hugh J Freeman, et al.
Published: (2010-01-01)

Potential of Using Walnuts as a Part of Nutritional Therapy for Inflammatory Bowel Diseases
by: Andrew V. Nalyotov, et al.
Published: (2025-02-01)

The Immunological Basis of Inflammatory Bowel Disease
by: Francesca A. R. Silva, et al.
Published: (2016-01-01)

Microbiota transplant therapy in inflammatory bowel disease: advances and mechanistic insights
by: Daphne Moutsoglou, et al.
Published: (2025-12-01)

Advanced biologic therapies and cardiovascular events in patients with inflammatory bowel disease
by: Lara Chaaban, et al.
Published: (2025-06-01)

Addressing the Critical Gap in Biological Therapies for Inflammatory Bowel Disease in Syria
by: Marouf Mouhammad Alhalabi
Published: (2025-04-01)

Horizon scanning: new and future therapies in the management of inflammatory bowel disease
by: Philip J Smith, et al.
Published: (2023-10-01)

Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies
by: Junjun Zhao, et al.
Published: (2021-01-01)

Persistence of biologic therapy in patients with inflammatory bowel diseases in the Chelyabinsk region
by: Anastasia I. Dolgushina, et al.
Published: (2025-01-01)

Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy
by: Helal F. Hetta, et al.
Published: (2024-10-01)